Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... in the area of central nervous system (CNS) disorders, including Huntington's disease, myasthenia gravis and Parkinson's disease. Additional information about Amarin is available at ...
2009 SEP 21 ... movement. Defects in this group of receptors or their loss causes diseases such as myasthenia gravis and epilepsy and can contribute to Alzheimer's disease, Parkinson's disease, and ...
2009 OCT 12 ... and controlled diplopia without major adverse effects at 2 years in patients with ocular myasthenia gravis (OMG). Questions remain as to whether study subjects had long-standing disease, biasing ...
2009 NOV 9 ... the clinical and electrophysiological characteristics of the larynx in patients with myasthenia gravis (MG). Thirty-two cases of MG were analyzed." "The laryngeal behaviors and ...
2009 NOV 16 ... likely also important for maintaining synaptic structure in adult muscle. In 5 to 7% of myasthenia gravis (MG) cases, the patients' blood contains antibodies to MuSK," researchers in ...
2009 SEP 14 ... kinase (MuSK) and sera or plasmas from patients with a subtype of the autoimmune disease myasthenia gravis in which patients have autoantibodies against MuSK. MuSK was robustly detected as the ...
2009 NOV 2 ... clinical course and management of a patient with submucous cleft palate who developed myasthenia gravis (MG) as an adult and suffered recurrent hypernasality. Few reports have described MG ...
2009 OCT 12 ... from Halle, Germany, "The preferred immunosuppressive drug for long term treatment of myasthenia gravis (MG) is azathioprine (AZA). Mycophenolate mofetil (MMF) was suggested as an effective ...
2009 OCT 12 ... is still uncertainty regarding risk factors for cancer occurrence in patients with myasthenia gravis (MG). The objective of this study is to determine the prevalence of extrathymic ...
2009 NOV 23 ... thymoma was diagnosed in a 14-year-old Samoyed dog with clinical symptoms of myasthenia gravis at 6 months of age. At necropsy, dark red-colored mass with many nodular protuberances ...
2009 OCT 5 ... 2 and 17 cells and regulatory T cells during the development of experimental autoimmune myasthenia gravis,' is newly published data in Immunology. According to a study from Harbin, People's ...
2009 NOV 24 ... "We report the case of a 17.5-year old girl with generalized myasthenia gravis (MG). When she was 13, she started to complain of episodic diplopia, ptosis and mild ...
2009 NOV 2 ... additional information, contact M.W. Nicolle, University of Western Ontario Hospital, Myasthenia Gravis Clinic, London Health Science Center, 339 Windermere Rd., London, ON N6A 5A5, Canada. ...
2009 NOV 9 ... According to recent research from Istanbul, Turkey, "The association of thymoma with myasthenia gravis has been well documented. However, the relationship between these two syndromes and ...
2009 NOV 23 ... cholinesterases. Inhibitors of acetylcholinesterase (AChE) are used in the treatment of myasthenia gravis, Alzheimer's disease, and in the prophylaxis of poisoning with organophosphates." ...
2009 NOV 16 ... records of 51 eyelids (33 patients) with ptosis secondary to cranial nerve 111 palsy, myasthenia gravis, chronic progressive external ophthalmoplegia, or oculopharyngeal dystrophy." ...
2009 OCT 5 ... Scientists discuss in 'Increasing incidence of elderly onset patients with myasthenia gravis in a local area of Japan' new findings in...
